Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Gyre Therapeutics (GYRE) Return on Assets (2016 - 2026)

Gyre Therapeutics has reported Return on Assets over the past 15 years, most recently at 0.0% for Q4 2025.

  • Quarterly Return on Assets changed 0.0% to 0.0% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0% through Dec 2025, changed 0.0% year-over-year, with the annual reading at 0.0% for FY2025, 0.0% changed from the prior year.
  • Return on Assets was 0.0% for Q4 2025 at Gyre Therapeutics, down from 0.0% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.0% in Q1 2023 and troughed at 0.02% in Q1 2022.
  • The 5-year median for Return on Assets is 0.01% (2024), against an average of 0.01%.
  • Year-over-year, Return on Assets decreased -1bps in 2021 and then rose 2bps in 2023.
  • A 5-year view of Return on Assets shows it stood at 0.01% in 2021, then surged by 106bps to 0.0% in 2022, then crashed by -1913bps to 0.01% in 2023, then soared by 109bps to 0.0% in 2024, then crashed by -153bps to 0.0% in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Return on Assets are 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).